CD36 mRNA (log r.u.) | CD36 protein (log r.u.) | |||
---|---|---|---|---|

Type 2 diabetes | Nondiabetic control subjects | Type 2 diabetes | Nondiabetic control subjects | |

n | 33 | 27 | 33 | 27 |

Unadjusted mean | 0.23 ± 0.02^{†} | 0.16 ± 0.02 | 0.28 ± 0.02^{§} | 0.18 ± 0.02 |

Model 1 | 0.21 ± 0.02 | 0.17 ± 0.02 | 0.27 ± 0.01^{*} | 0.21 ± 0.02 |

Model 2 | 0.20 ± 0.02 | 0.18 ± 0.02 | 0.26 ± 0.01^{†} | 0.20 ± 0.01 |

CD36 mRNA (log r.u.) | NA | NA | r = 0.64^{‡} | r = 0.63^{‡} |

PPAR-γ mRNA (log r.u.) | r = 0.73^{‡} | r = 0.72^{‡} | r = 0.33^{#} | r = 0.46^{*} |

hsCRP (log mg/dl) | r = 0.55^{†} | r = 0.21 | r = 0.45^{†} | r = 0.43^{*} |

hsIL-6 (log pg/ml) | r = 0.40^{*} | r = 0.49^{†} | r = 0.64^{‡} | r = 0.49^{†} |

TNF-α (log pg/ml) | r = −0.20 | r = 0.09 | r = −0.28 | r = −0.02 |

Adiponectin (log μg/ml) | r = −0.61^{‡} | r = −0.67^{‡} | r = −0.60^{‡} | r = −0.56^{†} |

BMI (kg/m^{2}) | r = 0.20 | r = 0.03 | r = 0.09 | r = 0.17 |

HOMA-IR (log r.u.) | r = 0.18 | r = 0.03 | r = 0.12 | r = −0.07 |

QUICKI (log r.u.) | r = −0.20 | r = 0.05 | r = −0.16 | r = 0.19 |

Data are least squares means ± SEM unless otherwise indicated. The

*P*value is from a*t*test of equality of the means. Model 1 adjusts for hypertension (HTN), hsIL-6, PPAR, adiponectin, and QUICKI. Model 2 adjusts for hsIL-6, adiponectin, and QUICKI.↵*

*P*< 0.05,↵†

*P*< 0.01,↵‡

*P*< 0.001,↵§

*P*< 0.0001,↵#

*P*= 0.08. HOMA-IR, homeostasis model assessment–insulin resistance; QUICKI, quantitative insulin sensitivity check index; r.u., relative units.